Microscopic Polyangiitis

PR3-AAV Resilient Remission or PRRR

Hydroxychloroquine in ANCA Vasculitis Evaluation

Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases

Low Dose Naltrexone to Improve Physical Health in Patients With Vasculitis

One-Time DNA Study for Vasculitis

VCRC Tissue Repository

Biosimilars of Rituximab in ANCA-associated Vasculitis Compared to the Originator

Study Evaluating SC291 in Subjects With Severe r/r B-cell Mediated Autoimmune Diseases (GLEAM)

Efficacy Study of Two Treatments in the Remission of Vasculitis

Comparison Study of Two Rituximab Regimens in the Remission of ANCA Associated Vasculitis

Fourth-gen CAR T Cells Targeting BCMA/CD19 for Refractory Systemic Lupus Erythematosus (SLE)

Establishment of an ELISA for the Recognition of Procalcitonin Variants in Patients With Hyperprocalcitonemia.

Pediatric Vasculitis Initiative

PRagmatic Analysis of Vitamin D in ANCA-Associated Vasculitis

Longitudinal Protocol for Granulomatosis With Polyangiitis (Wegener's) and Microscopic Polyangiitis

Rituximab Vasculitis Maintenance Study

Pilot Study of Short-Course Glucocorticoids and Rituximab for Treatment of ANCA-Associated Vasculitis

Low-dose Glucocorticoid Vasculitis Induction Study

Pharmacokinetic Study of Rituximab Induction Regimen in ANCA-associated Vasculitis

VCRC Patient Contact Registry Patient-Reported Data Validation Study